Navigation Links
FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing
Date:11/14/2007

NUTLEY, N.J., Nov. 14 /PRNewswire-USNewswire/ -- Roche announced today that the U.S. Food and Drug Administration (FDA) has approved MIRCERA (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia associated with chronic renal failure (CRF) in adults, including patients on dialysis and patients not on dialysis. CRF is commonly known as chronic kidney disease (CKD). MIRCERA is the only FDA-approved erythropoiesis-stimulating agent (ESA) to provide correction of anemia with once-every-two-week dosing. MIRCERA is also the only FDA-approved ESA to maintain stable hemoglobin levels with once-monthly or once-every-two-week dosing in CKD patients. MIRCERA offers the added convenience of storage at room temperature for extended time periods when necessary.

The outcome of an ongoing patent case will determine when patients can gain access to MIRCERA in the United States. Following approval by the European Agency for the Evaluation of Medicinal Products (EMEA), MIRCERA has already been launched in Austria, Sweden, Germany, the United Kingdom and Norway, and will continue its international rollout.

"Roche is pleased that the approved FDA label reflects the differentiating characteristics of MIRCERA," said George B. Abercrombie, President and Chief Executive Officer, Hoffmann-La Roche Inc. "In Europe, thousands of patients with chronic renal failure and their physicians are receiving effective, predictable and convenient anemia treatment with MIRCERA, and we are hopeful that patients and healthcare providers in the U.S. will be able to have access to MIRCERA as soon as possible, in a responsible and legal manner."

In contrast to erythropoietin, MIRCERA is an erythropoietin receptor activator with greater activity in vivo as well as increased half-life. MIRCERA has the longest half-life of all FDA-approved ESAs, up to six times longer than darbepoetin alfa and up to 20 times longer than epoetin.

The initial registration clinical
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... -- Polio is history in much of the world, ... Pakistan. Giving vaccinated children an extra dose of inactivated ... the highly infectious disease, a new study suggests. ... as early as a year after vaccination. Vaccinated children ... the spread of the disease, according to background information ...
(Date:7/11/2014)... new study challenges the widely held belief that light drinking ... analyzed more than 50 studies that examined drinking habits and ... that those with a form of a gene tied to ... affects how a person,s body breaks down alcohol, resulting in ... variant has been shown to lead to lower drinking over ...
(Date:7/11/2014)... is now providing worldwide clients with the most fashionable ... comes to buying summer wedding dresses online, ladies become ... of beautiful wedding gowns. Recently, the company has launched ... , The company’s current promotion is specially launched ... newest fashion trends. The top experts from AngelWeddingDress want ...
(Date:7/11/2014)... 11, 2014 American Farmer is proud ... Tuesday, July 15, 2014, at 8:30 am ET. , ... proprietary products, which are designed and formulated for use ... learn how these products help the crop realize its ... it is grown. , The show also features UniSouth ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Alliance Labs ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , In this episode, Innovations will explore ... 100mg docusate sodium in polyethylene glycol base designed to ... how the formulation functions as a hyperosmotic laxative by ...
Breaking Medicine News(10 mins):Health News:Researchers Assess New Way to Boost Polio Immunity 2Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:New Episode of American Farmer Featuring Sunbelt, UniSouth Genetics, and Michigan Milk Producers Association Airing on RFD-TV 2Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... Concentra ("Concentra" or the,"Company"), a national leader ... unique combination of medical services and general wellness ... Oregon, is known for its,safe, reliable air transportation ... was searching for an on-site health program that,matched ...
... revenues of $77.8 million, up 11% from,the prior year - Earnings per ... over the second quarter of 2007 - Operating cash flow of ... ... life,sDHA(TM), COLUMBIA, Md., Sept. 5 Martek Biosciences,Corporation (Nasdaq: MATK ...
... BOHEMIA, N.Y., Sept. 5 NBTY, Inc. (NYSE: NTY ), (http://www.NBTY.com ), a leading global manufacturer and marketer of ... follows (amounts,are rounded):, ... ... FOR THE MONTH OF AUGUST ...
... PARIS, Sept. 5 Sanofi-aventis announced the,publication of ... which,demonstrated that dronedarone (MULTAQ(TM)), a new anti-arrhythmic agent ... placebo in,maintaining sinus rhythm while not promoting pro-arrhythmias ... atrial fibrillation,(AF) and atrial flutter (AFL). AF, ...
... trauma patients, study finds , , WEDNESDAY, Sept. 5 (HealthDay ... does not reduce the need for blood transfusions among ... trauma patients. , The drug, epoetin alfa (brand ... because of potentially dangerous side effects. , "Unlike prior ...
... Club and Spa will soon have an East Valley location, ... DMB Executives, another first class Village Health Club and Spa ... Chandler,Arizona. As of July 31st, the land at the corner ... club design has been approved. The,purchase of the 7.3 acres ...
Cached Medicine News:Health News:Concentra Expands Horizon Air Employee Health Program With On-Site Clinic 2Health News:Martek Announces Third Quarter 2007 Financial Results 2Health News:Martek Announces Third Quarter 2007 Financial Results 3Health News:Martek Announces Third Quarter 2007 Financial Results 4Health News:Martek Announces Third Quarter 2007 Financial Results 5Health News:Martek Announces Third Quarter 2007 Financial Results 6Health News:Martek Announces Third Quarter 2007 Financial Results 7Health News:Martek Announces Third Quarter 2007 Financial Results 8Health News:Martek Announces Third Quarter 2007 Financial Results 9Health News:Martek Announces Third Quarter 2007 Financial Results 10Health News:Martek Announces Third Quarter 2007 Financial Results 11Health News:Martek Announces Third Quarter 2007 Financial Results 12Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 2Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 4Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 5Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 2Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 3Health News:Ocotillo in Chandler Will Have a Village 2
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  ... to sales of $2,202,000 for the prior year period, an ... also shown growth over the preceding quarter,s sales, continuing a ... year. Markets that experienced sales increases over the prior year ...
(Date:1/15/2014)... 2014 As health officials across the Midwest warn against ... in Michigan will offer free diagnostic ... Meijer pharmacists to administer tests and, in some cases, fill ... participating in the study. The Grand ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
Inquire...
... Designed for the elegant and ... Avenue collection includes ophthalmic and ... in a variety of shapes ... many face shapes and complexions. ...
... updated styling through the use of innovative ... collection is for the value driven consumer ... Eyewear Collection , The futuristic quality ... of the "strongest and lightest metal on ...
Inquire...
Medicine Products: